Anthropometric, clinical and biochemical characteristics in non NAFLD and NAFLD groups of both genders.

Results are expressed as number (percentage), mean ± SD; n = number of subjects; SGPT, serum glutamate pyruvate transaminase; GGT, gama glutamate transaminase; SGOT, serum glutamate oxaloacetate transaminase; HOMA%B, β cell function assessed by homeostasis model assessment; HOMA%S: insulin sensitivity assessed by homeostasis model assessment; HOMA-IR, insulin resistance assessed by homeostasis model assessment; NAFLD, nonalcoholic fatty liver disease.Anthropometric, clinical and biochemical characteristics in non NAFLD and NAFLD groups of both genders.结果以例数（百分比）、均值±标准差（Standard Deviation，SD）表示；n为受试者例数；血清谷氨酸丙酮酸转氨酶（serum glutamate pyruvate transaminase，SGPT）；γ-谷氨酰转移酶（gamma glutamate transaminase，GGT）；血清谷氨酸草酰乙酸转氨酶（serum glutamate oxaloacetate transaminase，SGOT）；稳态模型评估β细胞功能（HOMA%B）；稳态模型评估胰岛素敏感性（HOMA%S）；稳态模型评估胰岛素抵抗（HOMA-IR）；非酒精性脂肪性肝病（nonalcoholic fatty liver disease，NAFLD）。本数据集涵盖不同性别中非酒精性脂肪性肝病组与非NAFLD组的人体测量学、临床及生化特征。